Items in cart [0]

HARDBACK price:$42.95 add to cart Rights & Permissions Free PDF Access Sign in to download PDF book and chapters Free Resources PDF SUMMARY Display this book on your site! Related Titles Pathways of Addiction: Opportunities in Drug Abuse Research Marijuana As Medicine?: The Science Beyond the Controversy Other Related Titles Marijuana and Medicine: Assessing the Science Base (1999) Institute of Medicine (IOM) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager National Research Council. "Appendix B Workshop Agendas." Marijuana and Medicine: Assessing the Science Base. Washington, DC: The National Academies Press, 1999. 1. Print. Please select a format: Page 232   E-mail  Buzz This  Facebook  Delicious  Stumble  Twitter More The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Page 232 Appendix B Workshop Agendas Workshop on Perspectives on the Medical Use of Marijuana: Basic and Clinical Science December 14-16, 1997 Beckman Center, Irvine, California AGENDA Sunday, December 14,1997 2:00 p.m.  Introduction Constance Pechura, IOM Division Director, Neuroscience and Behavioral Health 2:30 p.m.  Public Input Session, 5 minutes per person Moderator: Stanley Watson, Jr., IOM Study Investigator, University of Michigan 5:30 p.m.  ADJOURN Page 232 Front Matter (R1-R18) Executive Summary (1-12) 1 Introduction (13-32) 2 Cannabinoids and Animal Physiology (33-82) 3 First, Do No Harm: Consequences of Marijuana Use and Abuse (83-136) 4 The Medical Value of Marijuana and Related Substances (137-192) 5 Development of Cannabinoid Drugs (193-222) Appendix A Individuals and Organizations That Spoke or Wrote to the Institute of Medicine About Marijuana and Medicine (223-231) Appendix B Workshop Agendas (232-239) Appendix C Scheduling Definitions (240-241) Appendix D Statement of Task (242-243) Appendix E Recommendations Made in Recent Reports on the Medical Use of Marijuana (244-255) Appendix F Rescheduling Criteria (256-258) Index (259-267)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 232
Page 232 Appendix B Workshop Agendas Workshop on Perspectives on the Medical Use of Marijuana: Basic and Clinical Science December 14-16, 1997 Beckman Center, Irvine, California AGENDA Sunday, December 14,1997 2:00 p.m.  Introduction Constance Pechura, IOM Division Director, Neuroscience and Behavioral Health 2:30 p.m.  Public Input Session, 5 minutes per person Moderator: Stanley Watson, Jr., IOM Study Investigator, University of Michigan 5:30 p.m.  ADJOURN

OCR for page 233
Page 233 Monday, December 15, 1997 CANNABINOID NEUROSCIENCE 8:30 a.m.  Moderator: Stanley Watson, IOM Study Investigator, University of Michigan 8:45 a.m.  Neuropharmacology of Cannabinoids and Their Receptors Steven R. Childers, Wake Forest University School of Medicine 9:15 a.m.  Precipitated Cannabinoid Withdrawal and Sensory Processing of Painful Stimuli J. Michael Walker, Brown University 9:45 a.m.  Role of Cannabinoids in Movement Clara Sanudo, Brown University 10:15 a.m. Tolerance and Cannabinoid-Opioid Interactions Sandra P. Welch, Medical College of Virginia 10:45 a.m. BREAK MEDICAL USES OF MARIJUANA: CLINICAL DATA AND BASIC BIOLOGY 11:10 a.m. Moderator: John A. Benson, Jr., IOM Study Investigator, Oregon Health Sciences University 11:15 a.m. Profile of Medical Marijuana Users John Mendelson, University of California at San Francisco 11:45 a.m. Immune Modulation by Cannabinoids Norbert Kaminski, Michigan State University 12:15 p.m. Psychological Effects of Marijuana Use Charles R. Schuster, Wayne State University 12:45 p.m. LUNCH

OCR for page 234
Page 234 1:45 p.m.  Marijuana and Glaucoma Paul Kaufman, University of Wisconsin 2:15 p.m.  Effects of Marijuana and Cannabinoids in Neurological Disorders Paul Consroe, University of Arizona Health Sciences Center 2:45 p.m.  Neural Mechanisms of Cannabinoid Analgesia Howard Fields, University of California at San Francisco 3:15 p.m. Pain Management Michael Rowbotham, University of California at San Francisco 3:45 p.m.  Wasting Syndrome Pathogenesis and Clinical Markers Donald Kotler, St. Luke's-Roosevelt Hospital 4:15 p.m.  Clinical Experience with Marijuana Stephen O'Brien, East Bay AIDS Center 4:45 p.m. ADJOURN Tuesday, December 16,1997 MEDICAL USES OF MARIJUANA: CLINICAL DATA AND BASIC BIOLOGY 8:30 a.m.  Moderator: John A. Benson, Jr., IOM Study Investigator, Oregon Health Sciences University 8:45 a.m.  Marijuana in AIDS Wasting: Tribulations and Trials Donald I. Abrams, University of California at San Francisco 9:15 a.m.  Nausea and Vomiting: Underlying Mechanisms and Upcoming Treatments Alan D. Miller, The Rockefeller University 9:45 a.m.  Postchemotherapy Nausea and Antiemetics Richard J. Gralla, Ochsner Cancer Center

OCR for page 235
Page 235 10:15 a.m. BREAK SUMMARY VIEWS 10:30 a.m. Marijuana Is Different from THC: A Review of Basic Research and State Studies of Antiemesis Richard E. Musty, University of Vermont 11:00 a.m. Medical Uses of Crude Marijuana: Medical and Social Issues Eric A. Voth, The International Drug Strategy Institute 11:30 a.m. General Questions Moderator: John A. Benson, Jr., IOM Study Investigator 12:00 noon ADJOURN

OCR for page 236
Page 236 Workshop on Acute and Chronic Effects of Marijuana Use January 22-23, 1998 New Orleans Marriott Hotel New Orleans, Louisiana AGENDA Thursday, January 22, 1998 2:00 p.m.  Introduction Constance Pechura, IOM Division Director, Neuroscience and Behavioral Health 2:30 p.m.  Public Input Session, 5 minutes per person Moderator: Stanley Watson, Jr., IOM Study Investigator, University of Michigan 4:30 p.m. ADJOURN Friday, January 23, 1998 8:30 a.m.  Moderator: John A. Benson, Jr., IOM Study Investigator, Oregon Health Sciences University HEALTH CONSEQUENCES OF MARIJUANA USE 9:00 a.m.  Health Consequences of Marijuana Use: Epidemiological Studies Stephen Sidney, Kaiser Permanente, Oakland, CA 9:30 a.m.  Immunity, Infections, and Cannabinoids Thomas Klein, University of South Florida 10:00 a.m. Pulmonary Effects of Smoked Marijuana Donald Tashkin, Unversity of California at Los Angeles 10:30 a.m. BREAK

OCR for page 237
Page 237 10:45 a.m. Is Marijuana Carcinogenic?: Epidemiological and Biological Evidence Panel Discussion Stephen Sidney Donald Tashkin 12:00 noon    LUNCH EFFECTS OF MARIJUANA ON BEHAVIOR 1:30 p.m.  Marijuana: Addictive and Amotivational States, the Scientific Evidence John Morgan, City University of New York Medical School 2:00 p.m.  Marijuana's Acute Behavioral Effects in Humans Richard Foltin, Columbia University 2:30 p.m.  Tolerance and Dependence Following Chronic Administration of Oral THC or Smoked Marijuana to Humans Margaret Haney, Columbia University 3:00 p.m.  Patterns of Continuity and Discontinuity of Marijuana Use in Relationship to Other Drugs Robert Pandina, Rutgers University 3:30 p.m.  ADJOURN

OCR for page 238
Page 238 Workshop on Prospects for Cannabinoid Drug Development February 23-24, 1998 National Academy of Sciences Building Washington, D.C. AGENDA Monday, February 23,1998 1:30 p.m.  Introduction Constance Pechura, IOM Division Director, Neuroscience and Behavioral Health 2:00 p.m.  Public Input Session, 5 minutes per person Moderator: John A. Benson, Jr., IOM Study Investigator, Oregon Health Sciences University 5:30 p.m.  ADJOURN Tuesday, February 24,1998 8:30 a.m.  Introduction Constance Pechura, IOM Division Director Neuroscience and Behavioral Health Moderator: Stanley J. Watson, Jr., IOM Study Investigator, University of Michigan OVERVIEWS OF PRECEDING WORKSHOPS 8:45 a.m.  Acute and Chronic Effects of Marijuana Billy R. Martin, Medical College of Virginia 9:25 a.m.  Perspectives on the Medical Use of Marijuana Eric B. Larson, University of Washington Medical School 9:55 a.m.  The Neurobiology of Cannabinoid Dependence George F. Koob, Scripps Research Institute 10:25 a.m. BREAK

OCR for page 239
Page 239 DRUG DEVELOPMENT 10:45 a.m. Regulatory Requirements Affecting Marijuana J. Richard Crout, Crout Consulting 11:15 a.m. Marinol and the Market Robert E. Dudley, Unimed Pharmaceuticals, Inc. 11:45 a.m. Development of Cannabis-based Therapeutics Dave Pate, HortaPharm, B.V. 12:15 p.m. LUNCH DRUG DELIVERY 1:30 p.m.  Alternative Drug Delivery Technologies for the Therapeutic Use of Marijuana Phyllis I. Gardner, ALZA Corporation, Stanford University 2:00 p.m.  Delivery of Analgesics via the Respiratory Track Reid M. Rubsamen, Aradigm Corporation 2:30 p.m.  Current Concepts for Delivery of THC Mahendra G. Dedhiya, Roxanne Laboratories, Inc. 3:00 p.m.  D9-THC-Hemisuccinate in Suppository Formulation: An Alternative to Oral and Smoked THC Mahmoud A. ElSohly, University of Mississippi, ElSohly Laboratories, Inc. 3:30 p.m. Concluding Remarks John A. Benson, Jr., IOM Study Investigator, Oregon Health Sciences University 3:45 p.m. ADJOURN

Representative terms from entire chapter:

iom study ?>